Clearpoint Neuro Inc reports results for the quarter ended in March - Earnings Summary

Clearpoint Neuro

11/05/2023 23:37

* Clearpoint Neuro Inc  CLPT.OQ  reported a quarterly
adjusted
loss of 23 cents​​ per share for the quarter ended in March. The
mean expectation of two analysts for the quarter was for a loss
of 18 cents per share.
    * Revenue rose 8% to $5.43 million from a year ago; analysts
expected $5.11 million. 
    * Clearpoint Neuro Inc's reported EPS for the quarter was a
loss
of 23 cents​.
    * The mean earnings estimate of analysts had fallen by
about 8.8%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Clearpoint Neuro Inc shares had risen by 14.0% this
quarter and
gained 13.6% so far this year.
    * The company reported a quarterly loss of $5.61 million.
    * Wall Street's median 12-month price target for Clearpoint
Neuro
Inc is $18.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
11 at 10:37 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.18          -0.23          Missed
 Dec. 31 2022      -0.20          -0.18          Beat
 Sep. 30 2022      -0.19          -0.15          Beat
 Jun. 30 2022      -0.18          -0.18          Met